"Also, the ability to identify patients at increased risk may guide selection of therapeutic protocols that will maximise treatment outcomes while simultaneously minimising the risk of long-term complications among children diagnosed with cancer," said one of the researchers Kirsten Ness from St.Jude Children's Research Hospital in Memphis, US.